{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:41:20Z","timestamp":1772804480098,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India.","award":["NPLC-SSSharma"],"award-info":[{"award-number":["NPLC-SSSharma"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10557-017-6732-3","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T05:54:03Z","timestamp":1499666043000},"page":"255-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression"],"prefix":"10.1007","volume":"31","author":[{"given":"Yogesh","family":"Bulani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam Sunder","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,10]]},"reference":[{"issue":"6","key":"6732_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595\u2013602.","journal-title":"Am J Cardiol"},{"issue":"19","key":"6732_CR2","first-page":"2035","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study JAMA. 1979;241(19):2035\u20138.","journal-title":"The Framingham study JAMA"},{"issue":"25","key":"6732_CR3","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115(25):3213\u201323.","journal-title":"Circulation"},{"issue":"4","key":"6732_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.acvd.2011.11.007","volume":"105","author":"L Ernande","year":"2012","unstructured":"Ernande L, Derumeaux G. Diabetic cardiomyopathy: myth or reality? Arch Cardiovasc Dis. 2012;105(4):218\u201325.","journal-title":"Arch Cardiovasc Dis"},{"issue":"5","key":"6732_CR5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.RES.0000207406.94146.c2","volume":"98","author":"IG Poornima","year":"2006","unstructured":"Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res. 2006;98(5):596\u2013605.","journal-title":"Circ Res"},{"issue":"9","key":"6732_CR6","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2337\/dc08-zb09","volume":"31","author":"ZT Bloomgarden","year":"2008","unstructured":"Bloomgarden ZT. Glycemic control in diabetes: a tale of three studies. Diabetes Care. 2008;31(9):1913\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"6732_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ecl.2006.05.002","volume":"35","author":"DA Cesario","year":"2006","unstructured":"Cesario DA, Brar R, Shivkumar K. Alterations in ion channel physiology in diabetic cardiomyopathy. Endocrinol Metab Clin N Am. 2006;35(3):601\u201310. ix-x","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"6732_CR8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0735-1097(95)00518-8","volume":"27","author":"I Aoki","year":"1996","unstructured":"Aoki I, Shimoyama K, Aoki N, Homori M, Yanagisawa A, Nakahara K, et al. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes. J Am Coll Cardiol. 1996;27(3):560\u20136.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"6732_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0049-3848(03)00338-4","volume":"111","author":"G Ersoz","year":"2003","unstructured":"Ersoz G, Yakaryilmaz A, Turan B. Effect of sodium selenite treatment on platelet aggregation of streptozotocin-induced diabetic rats. Thromb Res. 2003;111(6):363\u20137.","journal-title":"Thromb Res"},{"issue":"11","key":"6732_CR10","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2003-030508","volume":"88","author":"M Romano","year":"2003","unstructured":"Romano M, Guagnano MT, Pacini G, Vigneri S, Falco A, Marinopiccoli M, et al. Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab. 2003;88(11):5321\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6732_CR11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI66125","volume":"123","author":"S Antoniak","year":"2013","unstructured":"Antoniak S, Owens AP 3rd, Baunacke M, Williams JC, Lee RD, Weithauser A, et al. PAR-1 contributes to the innate immune response during viral infection. J Clin Invest. 2013;123(3):1310\u201322.","journal-title":"J Clin Invest"},{"issue":"6","key":"6732_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063504","volume":"8","author":"KF Nickel","year":"2013","unstructured":"Nickel KF, Laux V, Heumann R, von Degenfeld G. Thrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension. PLoS One. 2013;8(6):e63504.","journal-title":"PLoS One"},{"issue":"4","key":"6732_CR13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00395-007-0653-4","volume":"102","author":"JL Strande","year":"2007","unstructured":"Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia\/reperfusion injury in rat hearts. Basic Res Cardiol. 2007;102(4):350\u20138.","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"6732_CR14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1161\/01.RES.86.10.1054","volume":"86","author":"A Sabri","year":"2000","unstructured":"Sabri A, Muske G, Zhang H, Pak E, Darrow A, Andrade-Gordon P, et al. Signaling properties and functions of two distinct cardiomyocyte protease-activated receptors. Circ Res. 2000;86(10):1054\u201361.","journal-title":"Circ Res"},{"issue":"3","key":"6732_CR15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1124\/jpet.107.133595","volume":"324","author":"JL Strande","year":"2008","unstructured":"Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. Inhibiting protease-activated receptor 4 limits myocardial ischemia\/reperfusion injury in rat hearts by unmasking adenosine signaling. J Pharmacol Exp Ther. 2008;324(3):1045\u201354.","journal-title":"J Pharmacol Exp Ther"},{"issue":"30","key":"6732_CR16","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.2174\/138161282130151007144725","volume":"21","author":"Y Bulani","year":"2015","unstructured":"Bulani Y, Sharma SS. Therapeutic potential of targeting protease activated receptors in cardiovascular diseases. Curr Pharm Des. 2015;21(30):4392\u20139.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"6732_CR17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/1074248413485434","volume":"18","author":"DL Sonin","year":"2013","unstructured":"Sonin DL, Wakatsuki T, Routhu KV, Harmann LM, Petersen M, Meyer J, et al. Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts. J Cardiovasc Pharmacol Ther. 2013;18(5):460\u201375.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"2","key":"6732_CR18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbrc.2009.04.105","volume":"384","author":"T Sakai","year":"2009","unstructured":"Sakai T, Nambu T, Katoh M, Uehara S, Fukuroda T, Nishikibe M. Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis. Biochem Biophys Res Commun. 2009;384(2):173\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"6732_CR19","doi-asserted-by":"crossref","first-page":"33030","DOI":"10.1038\/srep33030","volume":"6","author":"M Waasdorp","year":"2016","unstructured":"Waasdorp M, Duitman J, Florquin S, Spek CA. Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice. Sci Rep. 2016;6:33030.","journal-title":"Sci Rep"},{"issue":"4","key":"6732_CR20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","volume":"52","author":"K Srinivasan","year":"2005","unstructured":"Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313\u201320.","journal-title":"Pharmacol Res"},{"issue":"2","key":"6732_CR21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/en.2009-0661","volume":"151","author":"M Mihara","year":"2010","unstructured":"Mihara M, Aihara K, Ikeda Y, Yoshida S, Kinouchi M, Kurahashi K, et al. Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db\/db mice. Endocrinology. 2010;151(2):513\u20139.","journal-title":"Endocrinology"},{"issue":"9","key":"6732_CR22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","volume":"3","author":"P Pacher","year":"2008","unstructured":"Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc. 2008;3(9):1422\u201334.","journal-title":"Nat Protoc"},{"issue":"1","key":"6732_CR23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265\u201375.","journal-title":"J Biol Chem"},{"issue":"11","key":"6732_CR24","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2337\/db11-0549","volume":"60","author":"Y Ti","year":"2011","unstructured":"Ti Y, Xie GL, Wang ZH, Bi XL, Ding WY, Wang J, et al. TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model. Diabetes. 2011;60(11):2963\u201374.","journal-title":"Diabetes"},{"issue":"2","key":"6732_CR25","doi-asserted-by":"crossref","first-page":"H282","DOI":"10.1152\/ajpheart.00421.2008","volume":"296","author":"SA Marsh","year":"2009","unstructured":"Marsh SA, Dell'italia LJ, Chatham JC. Interaction of diet and diabetes on cardiovascular function in rats. Am J Physiol Heart Circ Physiol. 2009;296(2):H282\u201392.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6732_CR26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1475-2840-13-75","volume":"13","author":"SM Zhao","year":"2014","unstructured":"Zhao SM, Wang YL, Guo CY, Chen JL, Wu YQ. Progressive decay of Ca2+ homeostasis in the development of diabetic cardiomyopathy. Cardiovasc Diabetol. 2014;13:75.","journal-title":"Cardiovasc Diabetol"},{"issue":"6868","key":"6732_CR27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","volume":"415","author":"DM Bers","year":"2002","unstructured":"Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415(6868):198\u2013205.","journal-title":"Nature"},{"issue":"4","key":"6732_CR28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2337\/diabetes.51.4.1166","volume":"51","author":"SU Trost","year":"2002","unstructured":"Trost SU, Belke DD, Bluhm WF, Meyer M, Swanson E, Dillmann WH. Overexpression of the sarcoplasmic reticulum Ca (2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes. 2002;51(4):1166\u201371.","journal-title":"Diabetes"},{"issue":"12","key":"6732_CR29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1096\/fj.01-1019fje","volume":"16","author":"R Vetter","year":"2002","unstructured":"Vetter R, Rehfeld U, Reissfelder C, Weiss W, Wagner KD, Gunther J, et al. Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts. FASEB J. 2002;16(12):1657\u20139.","journal-title":"FASEB J"},{"issue":"5","key":"6732_CR30","doi-asserted-by":"crossref","first-page":"R1439","DOI":"10.1152\/ajpregu.00736.2007","volume":"295","author":"J Suarez","year":"2008","unstructured":"Suarez J, Scott B, Dillmann WH. Conditional increase in SERCA2a protein is able to reverse contractile dysfunction and abnormal calcium flux in established diabetic cardiomyopathy. Am J Physiol Regul Integr Comp Physiol. 2008;295(5):R1439\u201345.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2\u20133","key":"6732_CR31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12013-010-9084-1","volume":"57","author":"PK Mishra","year":"2010","unstructured":"Mishra PK, Metreveli N, Tyagi SC. MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochem Biophys. 2010;57(2\u20133):67\u201376.","journal-title":"Cell Biochem Biophys"},{"issue":"3","key":"6732_CR32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardiores.2004.10.041","volume":"65","author":"J Martin","year":"2005","unstructured":"Martin J, Kelly DJ, Mifsud SA, Zhang Y, Cox AJ, See F, et al. Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-\u03b2. Cardiovasc Res. 2005;65(3):694\u2013701.","journal-title":"Cardiovasc Res"},{"issue":"5","key":"6732_CR33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","volume":"133","author":"G Miric","year":"2001","unstructured":"Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats. Br J Pharmacol. 2001;133(5):687\u201394.","journal-title":"Br J Pharmacol"},{"issue":"19","key":"6732_CR34","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331(19):1286\u201392.","journal-title":"N Engl J Med"},{"issue":"9","key":"6732_CR35","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2337\/diabetes.51.9.2709","volume":"51","author":"KJ Way","year":"2002","unstructured":"Way KJ, Isshiki K, Suzuma K, Yokota T, Zvagelsky D, Schoen FJ, et al. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes. 2002;51(9):2709\u201318.","journal-title":"Diabetes"},{"issue":"4","key":"6732_CR36","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ajpath.2012.06.011","volume":"181","author":"KM Kassel","year":"2012","unstructured":"Kassel KM, Sullivan BP, Cui W, Copple BL, Luyendyk JP. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. Am J Pathol. 2012;181(4):1287\u201395.","journal-title":"Am J Pathol"},{"issue":"1\u20132","key":"6732_CR37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1024749614222","volume":"249","author":"B Huisamen","year":"2003","unstructured":"Huisamen B. Protein kinase B in the diabetic heart. Mol Cell Biochem. 2003;249(1\u20132):31\u20138.","journal-title":"Mol Cell Biochem"},{"issue":"1\u20132","key":"6732_CR38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2015.10.126","volume":"468","author":"PK Bagul","year":"2015","unstructured":"Bagul PK, Dinda AK, Banerjee SK. Effect of resveratrol on sirtuins expression and cardiac complications in diabetes. Biochem Biophys Res Commun. 2015;468(1\u20132):221\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"6732_CR39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.0000156076.17807.1F","volume":"96","author":"R Tian","year":"2005","unstructured":"Tian R. Another role for the celebrity: Akt and insulin resistance. Circ Res. 2005;96(2):139\u201340.","journal-title":"Circ Res"},{"issue":"5","key":"6732_CR40","doi-asserted-by":"crossref","first-page":"E1147","DOI":"10.1152\/ajpendo.00327.2009","volume":"297","author":"PE Shamhart","year":"2009","unstructured":"Shamhart PE, Luther DJ, Hodson BR, Koshy JC, Ohanyan V, Meszaros JG. Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium. Am J Physiol Endocrinol Metab. 2009;297(5):E1147\u201353.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"20","key":"6732_CR41","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.107.692764","volume":"116","author":"R Pawlinski","year":"2007","unstructured":"Pawlinski R, Tencati M, Hampton CR, Shishido T, Bullard TA, Casey LM, et al. Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation. 2007;116(20):2298\u2013306.","journal-title":"Circulation"},{"issue":"6","key":"6732_CR42","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/01.RES.0000035242.96310.45","volume":"91","author":"A Sabri","year":"2002","unstructured":"Sabri A, Short J, Guo J, Steinberg SF. Protease-activated receptor-1-mediated DNA synthesis in cardiac fibroblast is via epidermal growth factor receptor transactivation: distinct PAR-1 signaling pathways in cardiac fibroblasts and cardiomyocytes. Circ Res. 2002;91(6):532\u20139.","journal-title":"Circ Res"},{"issue":"1","key":"6732_CR43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","volume":"38","author":"HM Spronk","year":"2017","unstructured":"Spronk HM, De Jong AM, Verheule S, De Boer HC, Maass AH, Lau DH, et al. Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Eur Heart J. 2017;38(1):38\u201350.","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"6732_CR44","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1038\/sj.bjp.0707659","volume":"153","author":"PH Sugden","year":"2008","unstructured":"Sugden PH, Fuller SJ, Weiss SC, Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol. 2008;153(Suppl 1):S137\u201353.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"6732_CR45","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","volume":"51","author":"L Cai","year":"2002","unstructured":"Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes. 2002;51(6):1938\u201348.","journal-title":"Diabetes"},{"issue":"8","key":"6732_CR46","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2006.07.022","volume":"48","author":"L Cai","year":"2006","unstructured":"Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol. 2006;48(8):1688\u201397.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6732_CR47","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4103\/0971-5916.171290","volume":"142","author":"U Bhandari","year":"2015","unstructured":"Bhandari U, Kumar V, Kumar P, Tripathi CD, Khanna G. Protective effect of pioglitazone on cardiomyocyte apoptosis in low-dose streptozotocin & high-fat diet-induced type-2 diabetes in rats. Indian J Med Res. 2015;142(5):598\u2013605.","journal-title":"Indian J Med Res"},{"issue":"4","key":"6732_CR48","doi-asserted-by":"crossref","first-page":"H1728","DOI":"10.1152\/ajpheart.01328.2005","volume":"292","author":"Z Guo","year":"2007","unstructured":"Guo Z, Xia Z, Jiang J, McNeill JH. Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine. Am J Physiol Heart Circ Physiol. 2007;292(4):H1728\u201336.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"6732_CR49","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/db13-1896","volume":"64","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Kayama Y, Sakamoto M, Iuchi H, Shimizu I, Yoshino T, et al. Arachidonate 12\/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy. Diabetes. 2015;64(2):618\u201330.","journal-title":"Diabetes"},{"issue":"2","key":"6732_CR50","doi-asserted-by":"crossref","first-page":"H453","DOI":"10.1152\/ajpheart.00678.2008","volume":"296","author":"AP Kellogg","year":"2009","unstructured":"Kellogg AP, Converso K, Wiggin T, Stevens M, Pop-Busui R. Effects of cyclooxygenase-2 gene inactivation on cardiac autonomic and left ventricular function in experimental diabetes. Am J Physiol Heart Circ Physiol. 2009;296(2):H453\u201361.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"6732_CR51","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.ajpath.2011.07.015","volume":"179","author":"KM Kassel","year":"2011","unstructured":"Kassel KM, Owens AP 3rd, Rockwell CE, Sullivan BP, Wang R, Tawfik O, et al. Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a western diet. Am J Pathol. 2011;179(5):2278\u201389.","journal-title":"Am J Pathol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-017-6732-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-017-6732-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-017-6732-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T17:25:38Z","timestamp":1659201938000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-017-6732-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["6732"],"URL":"https:\/\/doi.org\/10.1007\/s10557-017-6732-3","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}